News | July 09, 2025
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
mRNA-1010 demonstrated superior relative vaccine efficacy
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Extended lab space for product development, customer demos, and training
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
Subscribe To Our Newsletter & Stay Updated
